I

Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager
Intercept Pharmaceuticals Inc
F:I4P
Watchlist
Price: 17.52 EUR Market Closed
Market Cap: 732.8m EUR
Have any thoughts about
Intercept Pharmaceuticals Inc?
Write Note

Intercept Pharmaceuticals Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Intercept Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
I
Intercept Pharmaceuticals Inc
F:I4P
Depreciation & Amortization
$377k
CAGR 3-Years
-50%
CAGR 5-Years
-40%
CAGR 10-Years
14%
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.4B
CAGR 3-Years
-1%
CAGR 5-Years
34%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.6B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$208.6m
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$469.5m
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
25%

See Also

What is Intercept Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
377k USD

Based on the financial report for Sep 30, 2023, Intercept Pharmaceuticals Inc's Depreciation & Amortization amounts to 377k USD.

What is Intercept Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
14%

Over the last year, the Depreciation & Amortization growth was -57%. The average annual Depreciation & Amortization growth rates for Intercept Pharmaceuticals Inc have been -50% over the past three years , -40% over the past five years , and 14% over the past ten years .

Back to Top